Brought to you by 
Anacor raises $7mm in Series A round
Oct 2002
Executive Summary
Anacor Pharmaceuticals (anti-infectives) received $7mm in its Series A financing from Aberdare Ventures and Rho Ventures. The round was completed in two tranches, with Anacor receiving $3mm in April, and the remaining $4mm this month.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Anacor raises $7mm in Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice